GRPR and cancer: Peptides generated by linking the gastrin-releasing peptide receptor (GRPR)-selective ligand to multiple bis-deoxygalactosyl-carborane building blocks showed selectivity for PC3 cancer cells but not for HepG2 cells, suggesting a reduced uptake into liver cells [136].